cmAngio® vs DeepRhythmAI
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to leverage existing mammography screenings for early cardiovascular risk assessment in women. This tool is ideal for identifying Breast Arterial Calcifications (BAC) without additional radiation or procedures, providing valuable insights for preventative cardiology and women's health initiatives.
View cmAngio® →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your focus is on enhancing the accuracy and efficiency of cardiac arrhythmia detection and classification from ECG data. This AI-powered solution is best suited for cardiologists and healthcare systems seeking to streamline ECG analysis, reduce missed diagnoses, and improve workflow for patients with suspected or known arrhythmias.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | DeepRhythmAI |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact vendor for pricing information |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®Tool A explicitly highlights 'quick and easy installation (less than an hour)' and 'Compatible with any DICOM-compliant viewer,' directly addressing ease of integration and user interaction with existing radiology workflows. While Tool B emphasizes workflow efficiency, Tool A's features directly speak to the simplicity of initial setup and daily use within a familiar environment.
Clinical Value
DeepRhythmAITool B makes strong, quantifiable claims of clinical impact, stating it 'reduces missed diagnoses (14x to 114x fewer)' and was 'Trained on 250 billion+ annotated heartbeats'. This robust evidence of superior accuracy in a critical diagnostic area gives it a clear edge in direct clinical benefit.
Pricing & Value
TieBoth tools lack transparent public pricing, requiring direct vendor contact for details. Without any specific cost information or clear value propositions beyond general benefits, it is impossible to compare their pricing or overall value effectively.
Enterprise Readiness
DeepRhythmAITool B explicitly targets 'Solo to large health systems,' has 'numerous healthcare providers globally' as customers, and offers an 'API available' for integration. These features demonstrate a strong focus on scalability, broad adoption, and seamless integration into diverse enterprise environments.
Innovation
cmAngio®Tool A offers a novel application of AI by detecting Breast Arterial Calcifications (BAC) on existing mammograms to provide insights into cardiovascular health. This repurposes readily available imaging data for a new, significant risk assessment, representing a more fundamental innovation in its application than enhancing an existing diagnostic process.
Support & Docs
TieNeither the provided structured facts nor general web searches offer specific details regarding customer support channels, service level agreements, or comprehensive documentation for either tool. Therefore, a meaningful comparison on this dimension is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | DeepRhythmAI |
|---|---|---|
| Product Name | cmAngiou00ae | DeepRhythmAI |
| Company | CureMetrix | Medicalgorithmics S.A. |
| Primary Function | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared, cloud-based AI algorithm for cardiac arrhythmia detection and classification from ECG data. |
| Key AI Focus | AI-based detection of Breast Arterial Calcifications (BAC) | AI-powered arrhythmia detection and classification |
| Target Medical Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and DeepRhythmAI.